Inova Translational Medicine Institute seeks partners to build a research network that will facilitate the discovery and validation of biomarkers.
Partnering with the Institute provides a unique opportunity for collaborators to leverage resources to accelerate the movement of targets from bedside through FDA submission. Collaborators will gain first access to intellectual property developed by Inova Translational Medicine Institute. In addition, partners gain access to the Institute's extensive biobank of samples for discovery and validation, from a wide variety of diseases states. With over 400 ongoing clinical trials, Inova is a leader in clinical research.
If your company is interested in a partnership with Inova Translational Medicine Institute, complete the form below.
